Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-25 @ 3:54 AM
NCT ID:
NCT02422602
Eligibility Criteria:
Inclusion Criteria:
* All patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current AMM) for less than one year whatever anti vitamin K treatment history
* Affiliate or beneficiary of a social security system.
* Patient who formulated its "does not oppose" to participate in this research
* Age higher than or equal to 18 years
Exclusion Criteria:
* Opposition to participation
* Patient don't understand french language
* Patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers)
* Tutorship or curatoship
* Law-protected patient
* Pregnant women or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02422602
Study Brief:
Protocol Section:
NCT02422602